Biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases
- Year invested 2010
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Associated Team
- Website rhythmtx.com
- Company Status IPO/Public (NASDAQ: RYTM)